Skip to main content
Top
Gepubliceerd in: Quality of Life Research 2/2017

02-08-2016

Mapping painDETECT, a neuropathic pain screening tool, to the EuroQol (EQ-5D-3L)

Auteurs: Joseph C. Cappelleri, Vijaya Koduru, E. Jay Bienen, Alesia Sadosky

Gepubliceerd in: Quality of Life Research | Uitgave 2/2017

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

To map relationships between painDETECT, a neuropathic pain (NeP) screening tool, and EQ-5D-3L health status in a real-world setting.

Methods

Patients with physician-confirmed NeP and painDETECT score classifications of nociceptive (n = 79), transitional (n = 141), and NeP (n = 386) completed the EuroQol (EQ-5D-3L), which evaluates Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression with three ordinal response levels (“no problem,” “some problems,” or “extreme problems/unable to do”), and has a health status thermometer (0 = worst health, 100 = perfect health). Multiple linear and logistic regressions were performed (adjusted for age, gender, race, ethnicity, time since NeP diagnosis, number of comorbidities, NeP conditions).

Results

Unadjusted mean (±SD) EQ-5D-3L thermometer scores showed poorer health status across painDETECT classifications from nociceptive (67.3 ± 22.1) to transitional (62.3 ± 20.9) to NeP (53.7 ± 21.8), as did utility scores, 0.695 ± 0.206, 0.615 ± 0.216, and 0.506 ± 0.216. In general, the highest odds of health problems were observed for NeP and the lowest for nociceptive, e.g., the NeP group was 6.2 (95 % confidence interval 3.4–11.4) times as likely to have a more severe problem of Usual Activities compared with the nociceptive group. Relative to nociceptive and transitional, NeP had lower adjusted mean thermometer scores, by 12.1 (P < 0.0001) and 7.8 (P = 0.0004) points, respectively, and lower mean utility scores by 0.157 (P < 0.0001) and 0.092 points (P < 0.0001).

Conclusions

This study, the first to map relationships between painDETECT and the EQ-5D-3L in a real-world setting, indicates that the patient burden with respect to pain classification can be characterized and quantified by decrements in health status overall and in specific domains. These data support the psychometric soundness of painDETECT, enhancing its use in pain management.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
2.
go back to reference van Hecke, O., Austin, S. K., Khan, R. A., Smith, B. H., & Torrance, N. (2014). Neuropathic pain in the general population: A systematic review of epidemiological studies. Pain, 155(4), 654–662.CrossRefPubMed van Hecke, O., Austin, S. K., Khan, R. A., Smith, B. H., & Torrance, N. (2014). Neuropathic pain in the general population: A systematic review of epidemiological studies. Pain, 155(4), 654–662.CrossRefPubMed
3.
go back to reference McDermott, A. M., Toelle, T. R., Rowbotham, D. J., Schaefer, C. P., & Dukes, E. M. (2006). The burden of neuropathic pain: results from a cross-sectional survey. European Journal of Pain, 10(2), 127–135.CrossRefPubMed McDermott, A. M., Toelle, T. R., Rowbotham, D. J., Schaefer, C. P., & Dukes, E. M. (2006). The burden of neuropathic pain: results from a cross-sectional survey. European Journal of Pain, 10(2), 127–135.CrossRefPubMed
4.
go back to reference Attal, N., Lanteri-Minet, M., Laurent, B., Fermanian, J., & Bouhassira, D. (2011). The specific disease burden of neuropathic pain: Results of a French nationwide survey. Pain, 152(12), 2836–2843.CrossRefPubMed Attal, N., Lanteri-Minet, M., Laurent, B., Fermanian, J., & Bouhassira, D. (2011). The specific disease burden of neuropathic pain: Results of a French nationwide survey. Pain, 152(12), 2836–2843.CrossRefPubMed
5.
go back to reference Langley, P. C., Van Litsenburg, C., Cappelleri, J. C., & Carroll, D. (2013). The burden associated with neuropathic pain in Western Europe. Journal of Medical Economics, 16(1), 85–95.CrossRefPubMed Langley, P. C., Van Litsenburg, C., Cappelleri, J. C., & Carroll, D. (2013). The burden associated with neuropathic pain in Western Europe. Journal of Medical Economics, 16(1), 85–95.CrossRefPubMed
6.
go back to reference Schaefer, C., Mann, R., Sadosky, A., Daniel, S., Parsons, B., Nieshoff, E., et al. (2014). Burden of illness associated with peripheral and central neuropathic pain among adults seeking treatment in the United States: A patient-centered evaluation. Pain Medicine, 15(12), 2105–2119.CrossRefPubMedPubMedCentral Schaefer, C., Mann, R., Sadosky, A., Daniel, S., Parsons, B., Nieshoff, E., et al. (2014). Burden of illness associated with peripheral and central neuropathic pain among adults seeking treatment in the United States: A patient-centered evaluation. Pain Medicine, 15(12), 2105–2119.CrossRefPubMedPubMedCentral
7.
go back to reference Attal, N., Cruccu, G., Baron, R., Haanpaa, M., Hansson, P., Jensen, T. S., et al. (2010). EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European Journal of Neurology, 17(9), 1113–1123.CrossRefPubMed Attal, N., Cruccu, G., Baron, R., Haanpaa, M., Hansson, P., Jensen, T. S., et al. (2010). EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European Journal of Neurology, 17(9), 1113–1123.CrossRefPubMed
8.
go back to reference Dworkin, R. H., O’Connor, A. B., Audette, J., Baron, R., Gourlay, G. K., Haanpaa, M. L., et al. (2010). Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clinic Proceedings, 85(3 Suppl), S3–14.CrossRefPubMedPubMedCentral Dworkin, R. H., O’Connor, A. B., Audette, J., Baron, R., Gourlay, G. K., Haanpaa, M. L., et al. (2010). Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clinic Proceedings, 85(3 Suppl), S3–14.CrossRefPubMedPubMedCentral
9.
go back to reference Bouhassira, D., Attal, N., Alchaar, H., Boureau, F., Brochet, B., Bruxelle, J., et al. (2005). Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain, 114(1–2), 29–36.CrossRefPubMed Bouhassira, D., Attal, N., Alchaar, H., Boureau, F., Brochet, B., Bruxelle, J., et al. (2005). Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain, 114(1–2), 29–36.CrossRefPubMed
10.
go back to reference Bennett, M. I., Attal, N., Backonja, M. M., Baron, R., Bouhassira, D., Freynhagen, R., et al. (2007). Using screening tools to identify neuropathic pain. Pain, 127(3), 199–203.CrossRefPubMed Bennett, M. I., Attal, N., Backonja, M. M., Baron, R., Bouhassira, D., Freynhagen, R., et al. (2007). Using screening tools to identify neuropathic pain. Pain, 127(3), 199–203.CrossRefPubMed
11.
go back to reference Freynhagen, R., Baron, R., Gockel, U., & Tolle, T. R. (2006). painDETECT: A new screening questionnaire to identify neuropathic components in patients with back pain. Current Medical Research and Opinion, 22(10), 1911–1920.CrossRefPubMed Freynhagen, R., Baron, R., Gockel, U., & Tolle, T. R. (2006). painDETECT: A new screening questionnaire to identify neuropathic components in patients with back pain. Current Medical Research and Opinion, 22(10), 1911–1920.CrossRefPubMed
12.
go back to reference Cappelleri, J. C., Bienen, E. J., Koduru, V., & Sadosky, A. (2014). Measurement properties of painDETECT by average pain severity. ClinicoEconomics and Outcomes Research, 6, 497–504.PubMedPubMedCentral Cappelleri, J. C., Bienen, E. J., Koduru, V., & Sadosky, A. (2014). Measurement properties of painDETECT by average pain severity. ClinicoEconomics and Outcomes Research, 6, 497–504.PubMedPubMedCentral
13.
go back to reference The EuroQol Group. (1990). EuroQol—a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef The EuroQol Group. (1990). EuroQol—a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef
14.
go back to reference Dakin, H. (2013). Review of studies mapping from quality of life or clinical measures to EQ-5D: An online database. Health Quality of Life Outcomes, 11, 151.CrossRefPubMedPubMedCentral Dakin, H. (2013). Review of studies mapping from quality of life or clinical measures to EQ-5D: An online database. Health Quality of Life Outcomes, 11, 151.CrossRefPubMedPubMedCentral
15.
go back to reference Torrance, N., Lawson, K. D., Afolabi, E., Bennett, M. I., Serpell, M. G., Dunn, K. M., et al. (2014). Estimating the burden of disease in chronic pain with and without neuropathic characteristics: Does the choice between the EQ-5D and SF-6D matter? Pain, 155(10), 1996–2004.CrossRefPubMedPubMedCentral Torrance, N., Lawson, K. D., Afolabi, E., Bennett, M. I., Serpell, M. G., Dunn, K. M., et al. (2014). Estimating the burden of disease in chronic pain with and without neuropathic characteristics: Does the choice between the EQ-5D and SF-6D matter? Pain, 155(10), 1996–2004.CrossRefPubMedPubMedCentral
16.
go back to reference Gu, N. Y., Bell, C., Botteman, M. F., Ji, X., Carter, J. A., & van Hout, B. (2012). Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores. Patient, 5(3), 185–197.PubMed Gu, N. Y., Bell, C., Botteman, M. F., Ji, X., Carter, J. A., & van Hout, B. (2012). Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores. Patient, 5(3), 185–197.PubMed
17.
go back to reference Baron, R., Tölle, T. R., Gockel, U., Brosz, M., & Freynhagen, R. (2009). A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms. Pain, 146(1–2), 34–40.CrossRefPubMed Baron, R., Tölle, T. R., Gockel, U., Brosz, M., & Freynhagen, R. (2009). A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms. Pain, 146(1–2), 34–40.CrossRefPubMed
18.
go back to reference Baron, R., Forster, M., & Binder, A. (2012). Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: A first step to a stratified treatment approach. Lancet Neurology, 11(11), 999–1005.CrossRefPubMed Baron, R., Forster, M., & Binder, A. (2012). Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: A first step to a stratified treatment approach. Lancet Neurology, 11(11), 999–1005.CrossRefPubMed
19.
go back to reference Freeman, R., Baron, R., Bouhassira, D., Cabrera, J., & Emir, B. (2014). Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs. Pain, 155(2), 367–376.CrossRefPubMed Freeman, R., Baron, R., Bouhassira, D., Cabrera, J., & Emir, B. (2014). Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs. Pain, 155(2), 367–376.CrossRefPubMed
20.
go back to reference Bouhassira, D., Wilhelm, S., Schacht, A., Perrot, S., Kosek, E., Cruccu, G., et al. (2014). Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: Data from the randomized, double-blind, COMBO-DN study. Pain, 155(10), 2171–2179.CrossRefPubMed Bouhassira, D., Wilhelm, S., Schacht, A., Perrot, S., Kosek, E., Cruccu, G., et al. (2014). Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: Data from the randomized, double-blind, COMBO-DN study. Pain, 155(10), 2171–2179.CrossRefPubMed
21.
go back to reference Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Medical Care, 43(3), 203–220.CrossRefPubMed Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Medical Care, 43(3), 203–220.CrossRefPubMed
22.
go back to reference Sadosky, A., Schaefer, C., Mann, R., Bergstrom, F., Baik, R., Parsons, B., et al. (2013). Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: Results from a retrospective chart review and cross-sectional survey. Diabetes Metabolic Syndrome Obesity, 5, 1–14.CrossRef Sadosky, A., Schaefer, C., Mann, R., Bergstrom, F., Baik, R., Parsons, B., et al. (2013). Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: Results from a retrospective chart review and cross-sectional survey. Diabetes Metabolic Syndrome Obesity, 5, 1–14.CrossRef
23.
go back to reference Mann, R., Bergstrom, F., Schaefer, C., Sadosky, A., Zlateva, G., Baik, R., et al. (2012). Characteristics of subjects with human immunodeficiency virus-related neuropathic pain in the United States: BEAT Neuropathic Pain Observational Study. Presented at: American Society of Regional Anesthesia and Pain Medicine 11th Annual Pain Medicine Meeting, Miami, FL, 15–18 November. Mann, R., Bergstrom, F., Schaefer, C., Sadosky, A., Zlateva, G., Baik, R., et al. (2012). Characteristics of subjects with human immunodeficiency virus-related neuropathic pain in the United States: BEAT Neuropathic Pain Observational Study. Presented at: American Society of Regional Anesthesia and Pain Medicine 11th Annual Pain Medicine Meeting, Miami, FL, 15–18 November.
24.
go back to reference Parsons, B., Schaefer, C., Mann, R., Sadosky, A., Daniel, S., Nalamachu, S., et al. (2013). Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United States. Journal of Pain Research, 6, 459–469.PubMedPubMedCentral Parsons, B., Schaefer, C., Mann, R., Sadosky, A., Daniel, S., Nalamachu, S., et al. (2013). Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United States. Journal of Pain Research, 6, 459–469.PubMedPubMedCentral
25.
go back to reference Mann, R., Bergstrom, F., Schaefer, C., Sadosky, A., Daniel, S., Parsons, B., et al. (2013). Burden of spinal cord injury-related neuropathic pain in the United States: Retrospective chart review and cross-sectional survey. Spinal Cord, 51(7), 564–570.CrossRefPubMed Mann, R., Bergstrom, F., Schaefer, C., Sadosky, A., Daniel, S., Parsons, B., et al. (2013). Burden of spinal cord injury-related neuropathic pain in the United States: Retrospective chart review and cross-sectional survey. Spinal Cord, 51(7), 564–570.CrossRefPubMed
26.
go back to reference Sadosky, A., Schaefer, C., Parsons, B., Baik, R., Mann, R., Bergstrom, F., et al. (2012). Characteristics of subjects with chronic low back pain-related neuropathic pain (CLBP-NeP) in the US: BEAT Neuropathic pain observational study [abstract]. Annals of Neurology, 72(Suppl), 117. Sadosky, A., Schaefer, C., Parsons, B., Baik, R., Mann, R., Bergstrom, F., et al. (2012). Characteristics of subjects with chronic low back pain-related neuropathic pain (CLBP-NeP) in the US: BEAT Neuropathic pain observational study [abstract]. Annals of Neurology, 72(Suppl), 117.
27.
go back to reference Schaefer, C., Mann, R., Sadosky, A., Daniel, S., Parsons, B., Nalamachu, S., et al. (2014). Health status, function, productivity, and costs among individuals with idiopathic painful peripheral neuropathy with small fiber involvement in the United States: Results from a retrospective chart review and cross-sectional survey. Journal of Medical Economics, 17(6), 394–407.CrossRefPubMed Schaefer, C., Mann, R., Sadosky, A., Daniel, S., Parsons, B., Nalamachu, S., et al. (2014). Health status, function, productivity, and costs among individuals with idiopathic painful peripheral neuropathy with small fiber involvement in the United States: Results from a retrospective chart review and cross-sectional survey. Journal of Medical Economics, 17(6), 394–407.CrossRefPubMed
28.
go back to reference Szende, A., Devlin, N., & Oppe, M. (2006). EQ-5D value sets: inventory, comparative review and user guide (p. 108). New York: EuroQol Group Monographs, Springer. Szende, A., Devlin, N., & Oppe, M. (2006). EQ-5D value sets: inventory, comparative review and user guide (p. 108). New York: EuroQol Group Monographs, Springer.
29.
go back to reference Sullivan, P. W., Ghushchyan, V., Wyatt, H. R., Wu, E. Q., & Hill, J. O. (2007). Impact of cardiometabolic risk factor clusters on health-related quality of life in the US. Obesity (Silver Spring), 15(2), 511–521.CrossRef Sullivan, P. W., Ghushchyan, V., Wyatt, H. R., Wu, E. Q., & Hill, J. O. (2007). Impact of cardiometabolic risk factor clusters on health-related quality of life in the US. Obesity (Silver Spring), 15(2), 511–521.CrossRef
30.
go back to reference Cleeland, C. S., & Ryan, K. M. (1994). Pain assessment: global use of the brief pain inventory. Annals of the Academy of Medicine, Singapore, 23(2), 129–138.PubMed Cleeland, C. S., & Ryan, K. M. (1994). Pain assessment: global use of the brief pain inventory. Annals of the Academy of Medicine, Singapore, 23(2), 129–138.PubMed
31.
go back to reference Kleinbaum, D. G., & Klein, M. (2010). Logistic regression. A self-learning text (3rd ed.). New York: Springer.CrossRef Kleinbaum, D. G., & Klein, M. (2010). Logistic regression. A self-learning text (3rd ed.). New York: Springer.CrossRef
32.
go back to reference Kleinbaum, D. G., Kupper, L. L., Nizam, A., & Rosenberg, E. S. (2014). Applied regression analysis and other multivariate methods (5th ed.). Boston: Cengage Learning. Kleinbaum, D. G., Kupper, L. L., Nizam, A., & Rosenberg, E. S. (2014). Applied regression analysis and other multivariate methods (5th ed.). Boston: Cengage Learning.
33.
go back to reference Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale: Lawrence Erlbaum Associates. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale: Lawrence Erlbaum Associates.
34.
go back to reference Pickard, A. S., Neary, M. P., & Cella, D. (2007). Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health and Quality Life Outcomes, 5, 70.CrossRef Pickard, A. S., Neary, M. P., & Cella, D. (2007). Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health and Quality Life Outcomes, 5, 70.CrossRef
35.
go back to reference Coteur, G., Feagan, B., Keininger, D. L., & Kosinski, M. (2009). Evaluation of the meaningfulness of health-related quality of life improvements as assessed by the SF-36 and the EQ-5D VAS in patients with active Crohn’s disease. Alimentary Pharmacology and Therapeutics, 29(9), 1032–1041.CrossRefPubMed Coteur, G., Feagan, B., Keininger, D. L., & Kosinski, M. (2009). Evaluation of the meaningfulness of health-related quality of life improvements as assessed by the SF-36 and the EQ-5D VAS in patients with active Crohn’s disease. Alimentary Pharmacology and Therapeutics, 29(9), 1032–1041.CrossRefPubMed
36.
go back to reference Zanini, A., Aiello, M., Adamo, D., Casale, S., Cherubino, F., Della Patrona, S., et al. (2015). Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD. Respiratory Care, 60(1), 88–95.CrossRefPubMed Zanini, A., Aiello, M., Adamo, D., Casale, S., Cherubino, F., Della Patrona, S., et al. (2015). Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD. Respiratory Care, 60(1), 88–95.CrossRefPubMed
37.
go back to reference Szende, A., & Janssen, B. (2014). Population norms for the EQ-5D. In J. M. Cabases, A. Szende, & B. Janssen (Eds.), Self-reported population health: An international perspective based on EQ-5D (pp. 19–30). Berlin: Springer.CrossRef Szende, A., & Janssen, B. (2014). Population norms for the EQ-5D. In J. M. Cabases, A. Szende, & B. Janssen (Eds.), Self-reported population health: An international perspective based on EQ-5D (pp. 19–30). Berlin: Springer.CrossRef
38.
go back to reference Sullivan, P. W., Lawrence, W. F., & Ghushchyan, V. (2005). A national catalog of preference-based scores for chronic conditions in the United States. Medical Care, 43(7), 736–749.CrossRefPubMed Sullivan, P. W., Lawrence, W. F., & Ghushchyan, V. (2005). A national catalog of preference-based scores for chronic conditions in the United States. Medical Care, 43(7), 736–749.CrossRefPubMed
39.
go back to reference Cappelleri, J. C., Koduru, V., Bienen, E. J., & Sadosky, A. (2015). A cross-sectional study examining the psychometric properties of the painDETECT measure in neuropathic pain. Journal of Pain Research, 8, 159–167.PubMedPubMedCentral Cappelleri, J. C., Koduru, V., Bienen, E. J., & Sadosky, A. (2015). A cross-sectional study examining the psychometric properties of the painDETECT measure in neuropathic pain. Journal of Pain Research, 8, 159–167.PubMedPubMedCentral
40.
go back to reference Ananth, C. V., & Kleinbaum, D. G. (1997). Regression models for ordinal responses: A review of methods and applications. International Journal of Epidemiology, 26(6), 1323–1333.CrossRefPubMed Ananth, C. V., & Kleinbaum, D. G. (1997). Regression models for ordinal responses: A review of methods and applications. International Journal of Epidemiology, 26(6), 1323–1333.CrossRefPubMed
41.
go back to reference Gu, N. Y., Botteman, M. F., Ji, X., Bell, C. F., Carter, J. A., & van Hout, B. (2011). Mapping of the Insomnia Severity Index and other sleep measures to EuroQol EQ-5D health state utilities. Health and Quality of Life Outcomes, 9, 119.CrossRefPubMedPubMedCentral Gu, N. Y., Botteman, M. F., Ji, X., Bell, C. F., Carter, J. A., & van Hout, B. (2011). Mapping of the Insomnia Severity Index and other sleep measures to EuroQol EQ-5D health state utilities. Health and Quality of Life Outcomes, 9, 119.CrossRefPubMedPubMedCentral
42.
go back to reference Sidovar, M. F., Limone, B. L., Lee, S., & Coleman, C. I. (2013). Mapping the 12-item multiple sclerosis walking scale to the EuroQol 5-dimension index measure in North American multiple sclerosis patients. BMJ Open. doi:10.1136/bmjopen-2013-002798. Sidovar, M. F., Limone, B. L., Lee, S., & Coleman, C. I. (2013). Mapping the 12-item multiple sclerosis walking scale to the EuroQol 5-dimension index measure in North American multiple sclerosis patients. BMJ Open. doi:10.​1136/​bmjopen-2013-002798.
43.
go back to reference Khan, K. A., Madan, J., Petrou, S., & Lamb, S. E. (2014). Mapping between the Roland Morris Questionnaire and generic preference-based measures. Value in Health, 17(6), 686–695.CrossRefPubMed Khan, K. A., Madan, J., Petrou, S., & Lamb, S. E. (2014). Mapping between the Roland Morris Questionnaire and generic preference-based measures. Value in Health, 17(6), 686–695.CrossRefPubMed
Metagegevens
Titel
Mapping painDETECT, a neuropathic pain screening tool, to the EuroQol (EQ-5D-3L)
Auteurs
Joseph C. Cappelleri
Vijaya Koduru
E. Jay Bienen
Alesia Sadosky
Publicatiedatum
02-08-2016
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 2/2017
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-016-1379-2

Andere artikelen Uitgave 2/2017

Quality of Life Research 2/2017 Naar de uitgave